Inhibitory effect of amygdalin on lipopolysaccharide-inducible TNF-α and IL-1β mRNA expression and carrageenan-induced rat arthritis

Journal of Microbiology and Biotechnology

Volumn 18, Issue 10, 2008, Pages 1641-1647

  Hwang, Hye Jeong ^a   Lee, Hye Jung ^a   Kim, Chang Ju ^b   Shim, Insop ^c   Hahm, Dae Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Amygdalin; Arthritis; c Fos; IL 1 ; Inflammation; Pain; TNF

Indexed keywords

AMYGDALIN; BIOLOGICAL MARKER; CARRAGEENAN; INDUCIBLE TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN C FOS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKLE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PAIN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPRAGUE DAWLEY RAT; WEIGHT BEARING;

AMYGDALIN; ANIMALS; ARTHRITIS; CARRAGEENAN; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; NITRILES; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 57849128927     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bethea, J. R., H. Nagashima, M. C. Acosta, C. Briceno, F. Gomez, A. E. Marcillo, K. Loor, J. Green, and W. D. Dietrich. 1999. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 16: 851-863.
2. Buritova, J., V. Chapman, P. Honore, and J. M. Besson. 1997. The contribution of peripheral bradykinin B2 receptors to carrageenan- evoked oedema and spinal c-Fos expression in rats. Eur. J. Pharmacol. 320: 73-80.
3. Chang, H. K., M. S. Shin, H. Y. Yang, J. W. Lee, Y. S. Kim, M. H. Lee, J. Kim, K. H. Kim, and C. J. Kim. 2006. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. Biol. Pharm. Bull. 29: 1597-1602.
4. Chang, H. K., H. Y. Yang, T. H. Lee, M. C. Shin, M. H. Lee, M. S. Shin, et al. 2005. Armeniacae semen extract suppresses lipopolysaccharide-induced expressions of cyclooxygenase [correction of cycloostygenase]-2 and inducible nitric oxide synthase in mouse BV2 microglial cells. Biol. Pharm. Bull. 28: 449-454.
5. Choy, E. H. and G. S. Panayi. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344: 907-916.
6. DeLeo, J. A., R. W. Colburn, and A. J. Rickman. 1997. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 759: 50-57.
7. Ellison, N. M., D. P. Byar, and G. R. Newell. 1978. Special report on Laetrile: The NCI Laetrile Review. Results of the National Cancer Institute's retrospective Laetrile analysis. N. Engl. J. Med. 299: 549-552.
8. Fukuta, T., H. Ito, T. Mukainaka, H. Tokuda, H. Nishino, and T. Yoshida. 2003. Anti-tumor promoting effect of glycosides from Prunus persica seeds. Biol. Pharm. Bull. 26: 271-273.
9. Handy, R. L. and P. K. Moore. 1998. A comparison of the effects of L-NAME, 7- NI and L-NIL on carrageenan-induced hindpaw edema and NOS activity. Br. J. Pharmacol. 123: 1119-1126.
10. Holsapple, M. P., M. Schnur, and G. K. Yim. 1980. Pharmacological modulation of edema mediated by prostaglandin, serotonin and histamine. Agents Actions 10: 368-373.
11. Honore, P., J. Buritova, and J. M. Besson. 1995. Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation. Pain 63: 365-375.
12. Laughlin, T. M., J. R. Bethea, R. P. Yezierski, and G. L. Wilcox. 2000. Cytokine involvement in dynorphin-induced allodynia. Pain 84: 159-167.
13. Lundeberg, T., P. Alstergren, A. Appelgren, B. Appelgren, J. Carleson, S. Kopp, and E. Theodorsson. 1996. A model for experimentally induced temperomandibular joint arthritis in rats: Effects of carrageenan on neuropeptide-like immunoreactivity. Neuropeptides 30: 37-41.
14. Moertel, C. G., T. R. Fleming, J. Rubin, L. K. Kvolis, G. Sarna, R. Koch, et al. 1982. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N. Engl. J. Med. 306: 201-206.
15. Park, H. J., S. H. Yoon, L. S. Han, L. T. Zheng, K. H. Jung, Y. K. Uhm, et al. 2005. Amygdalin inhibits genes related to cell cycle in SNU-C4 human colon cancer cells. World J. Gastroenterol. 11: 5156-5161.
16. Poon, A. and J. Sawynok. 1999. Antinociceptive and anti- inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor. Eur. J. Pharmacol. 384: 123-138.
17. Schaible, H. G., R. F. Schmidt, and W. D. Willis. 1987. Enhancement of the responses of ascending tract cells in the cat spinal cord by acute inflammation of the knee joint. Exp. Brain Res. 66: 489-499.
18. Schött, E., O. G. Berge, K. Angeby-Möller, G. Hammarstörm, C. J. Dalsgaard, and E. Brodin. 1994. Weight bearing as an objective measure of arthritic pain in the rat. J. Pharmacol. Toxicol. Methods 31: 79-83.
19. Sedgwick, A. D., A. R. Moore, A. Y. Al-Duaij, J. C. Edwards, and D. A. Willoughby. 1985. Studies into the influence of carrageenan- induced inflammation on articular cartilage degradation using implantation into air pouches. Br. J. Exp. Pathol. 66: 445-453.
20. Silvan, A. M., M. J. Abad, P. Bermejo, A. M. Villar, and J. P. Lopez-Bote. 1996. Aggravation of adjuvant arthritis by carrageenan. Gen. Pharmacol. 27: 639-642.
21. Stochla, K. and S. Maslinski. 1982. Carrageenan-induced oedema in the rat paw-histamine participation. Agents Actions 12: 201-202.
22. Sweitzer, S. M., R. W. Colburn, M. Rutkowski, and J. A. DeLeo. 1999. Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat. Brain Res. 829: 209-221.
23. Urban, M. O. and G. F. Gebhart. 1999. Supraspinal contributions to hyperalgesia. Proc. Natl. Acad. Sci. USA 96: 7687-7692.
24. Vinegar, R., J. F. Truax, J. L. Selph, P. R. Johnston, A. L. Venable, and K. K. McKenzie. 1987. Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed. Proc. 46: 118-126.
25. Watkins, L. R., S. F. Maier, and L. E. Goehler. 1995. Immune activation: The role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63: 289-302.
26. Wirth, K. J., H. G. Alpermann, R. Satoh, and M. Inazu. 1992. The bradykinin antagonist Hoe 140 inhibits carrageenan- and thermically induced paw oedema in rats. Agents Actions Suppl. 38: 428-431.
27. Zhang, Y., A. Shaffer, J. Portanova, K. Seibert, and P. C. Isakson. 1997. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J. Pharmacol. Exp. Ther. 283: 1069-1075.